Rubina Parmar is a seasoned professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as the Senior Vice President and Head of Technology at Atlas Venture since February 2025, Rubina previously held the position of Vice President of Chemistry & Delivery Sciences at Intellia Therapeutics, Inc. from September 2017 to January 2025. Prior roles include Lead Scientist/Associate Director at Alnylam Pharmaceuticals, where Rubina focused on the design and synthesis of novel nucleotide chemistries, and Associate Principal Scientist at Merck, contributing to the development of innovative platforms for siRNA delivery. Early in the career, Rubina worked at Sirna Therapeutics and Sigma Proligo, engaging in lipid design and oligonucleotide synthesis, respectively. Holding a Ph.D. in Organic Chemistry from Punjabi University, Rubina has made significant contributions to scientific literature and holds multiple patents.
This person is not in the org chart
This person is not in any teams
This person is not in any offices